Eli Lilly expands the manufacturing leadership bench ahead of more GLP-1 demand

INDIANAPOLIS — The constraint is not the molecule. It is the plant, the filler, and the person who can stand up both.

The company has hired two additional manufacturing vice presidents with biologics-fill experience, a sign the board would rather overbuild the org chart than miss another quarter of constrained supply.